The efficacy and safety of neoadjuvant buparlisib for breast cancer: A meta-analysis of randomized controlled studies

INTRODUCTION: The efficacy of neoadjuvant buparlisib for breast cancer remains controversial. We conduct a systematic review and meta-analysis to explore the influence of neoadjuvant buparlisib versus placebo for breast cancer. METHODS: We search PubMed, EMbase, Web of science, EBSCO, and Cochrane l...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qian, Lu, Hui, Zhou, Xian, Wang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946506/
https://www.ncbi.nlm.nih.gov/pubmed/31689768
http://dx.doi.org/10.1097/MD.0000000000017614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946506/
https://www.ncbi.nlm.nih.gov/pubmed/31689768
http://dx.doi.org/10.1097/MD.0000000000017614

Ejemplares similares